• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

cochlear

MedTech 100 roundup: Stocks were practically unchanged last week

August 24, 2020 By Sean Whooley

Despite plenty of ups and downs coming in the stock market for the medtech industry, there was hardly any movement from week to week. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.6 points at the end of last week (Aug. 21). Overall, medtech stocks saw […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Bayer, Cala Health, cochlear, conformis, CureVac, Fractyl Laboratories, Johnson and Johnson, momentapharmaceuticals, Principia Biopharma, S&P, Sanofi, Stryker, Teva Pharmaceuticals

FDA approves Cochlear sound processor

July 6, 2020 By Sean Whooley

Cochlear Ltd. (ASX:COH) announced today that it received FDA approval for three new products in its suite of implantable hearing technology. Lone Tree, Colo.-based Cochlear won approval for its Nucleus Kanso 2 sound processor, Nucleus 7 sound processor for Nucleus 22 implant recipients and Custom Sound Pro fitting software, according to a news release. Cochlear touts […]

Filed Under: Food & Drug Administration (FDA), Implants, Otolaryngology/Ear, Nose & Throat (ENT), Regulatory/Compliance Tagged With: cochlear, Cochlear Americas, Cochlear Ltd., FDA

Cochlear wins FDA approval to lower age to implant to 9 months

May 19, 2020 By Danielle Kirsh

Cochlear Ltd. (ASX:COH) has received FDA approval to lower the age of cochlear implantation to nine months for children. The new approval lowers the age from the original 12 months for children with bilateral, profound sensorineural hearing loss. Cochlear implants have been FDA approved for use in children since 1990. “In light of all that has […]

Filed Under: Pediatrics, Vision Tagged With: cochlear

Cochlear loses appeal over $268m in patent damages

March 17, 2020 By Sean Whooley

The U.S. Court of Appeals for the Federal Circuit upheld a U.S. District Court decision that awarded $268 million in damages from Cochlear Ltd. (ASX:COH) to two competitors in a patent dispute. Yesterday’s ruling comes after several years of legal battles over the patents for hearing implants, and likely won’t be the end, as Cochlear is […]

Filed Under: Business/Financial News, Featured, Legal News, Otolaryngology/Ear, Nose & Throat (ENT), Patent Infringement Tagged With: Advanced Bionics LLC, Alfred E. Mann Foundation, Alfred Mann Foundation, cochlear, cochlear implant, Cochlear Ltd.

FDA approves new MR-safe hearing device from Cochlear

June 17, 2019 By Danielle Kirsh

Cochlear Ltd. (ASX:COH) today announced that it received FDA approval for its Cochlear Nucleus cochlear implant and its Nucleus 7 sound processor. The Nucleus Profile Plus implant is designed for safe use in MRI scans and offer easier access to 1.5 and 3.0 Tesla MRI scans without having to remove its internal magnet or use a […]

Filed Under: Blog Tagged With: cochlear, Cochlear Americas

Cochlear joins $17m round for sleep apnea nueromod dev Nyxoah

November 14, 2018 By Fink Densford

Cochlear Ltd. (ASX:COH) has joined a $17.1 million (EU €15 million) funding round for Nyxoah to support the development and commercialization of its hypoglossal nerve stim therapy for treating obstructive sleep apnea. Australian hearing tech developer Cochlear lead the round, investing $14.7 million (EU €13 million). The round was also joined by several existing Nyxoah shareholders, […]

Filed Under: Business/Financial News, Respiratory Tagged With: cochlear, Nyxoah

These 10 medtech companies care a lot about research

October 17, 2018 By Danielle Kirsh

These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal […]

Filed Under: Cardiovascular, Featured, Imaging, Implants, Oncology, Orthopedics, Patient Monitoring, Regenerative Medicine, Research & Development Tagged With: Abiomed, Accuray Inc., AtriCure Inc., Big 100, BioMerieux Inc., cochlear, conformis, Dexcom, Edwards Lifesciences, Insulet, R&D, Sectra

Cochlear launches Nucleus app for Android devices

June 27, 2018 By Fink Densford

Cochlear Ltd. (ASX:COH) said today it launched a Google (NSDQ:GOOG) Android compatible version of its Nucleus smart application designed for use with its Nucleus 7 sound processor. With the update, users of the Nucleus 7 with Android devices can control their hearing through the linked application, and will gain access to a number of new features previously […]

Filed Under: Business/Financial News, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: cochlear

These 10 medtech companies care a lot about research

November 29, 2017 By Chris Newmarker

Among the world’s largest medtech companies, these 10 spent the largest portion of their budgets on research and development. So what have they produced? Every year, Medical Design & Outsourcing pulls financial regulatory filings and reaches out to major, companies in some cases to create a list of the 100 largest medical device companies in […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Research & Development Tagged With: Abiomed, Accuray Inc., Analogic, AtriCure Inc., Big 100, BioMerieux Inc., cochlear, Dexcom, Edwards Lifesciences, Insulet, Philips, Spectranetics Corp.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS